Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Guggenheim

Read How Analysts Reacted To Kohl's Conclusion Of Strategic Review Process

Telsey Advisory Group analyst Dana Telsey has lowered the price target on Kohl's Corp (NYSE:KSS) to $35 (19% upside) from $55 and kept the Market Perform rating on the shares. Kohl's abandoned its negotiations with Franchise Group, considering the challenges in the current retail and financing environment. Also, the retail chain has cut its Q2 sales guidance on ongoing inflationary…

New Chelsea owner Todd Boehly - how rich is he and how did he make his money?

New Chelsea owner Todd Boehly - how rich is he and how did he make his money?

Todd Boehly is to be the new face of Chelsea Football Club, as his consortium secures permission to complete the sale of the west London outfit from Roman Abramovic after he bought it in 2003

Todd Boehly’s vision for Chelsea? Glossy spectacle and ruthless profit

Todd Boehly’s vision for Chelsea? Glossy spectacle and ruthless profit

Judging by his time with the Los Angeles Dodgers, Boehly will sanction big spending as long as he sees even bigger returns

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

SVB Sees De-Risked Opportunity For This Newly Listed Norovirus Vaccine

SVB Leerink is initiating coverage of HilleVax Inc (NASDAQ:HLVX) shares with an Outperform rating and a $30 price target. The analyst believes the company’s potentially first-in-class infant norovirus vaccine HIL214 represents a uniquely de-risked opportunity. It estimates $625 million in risk-adjusted infant HIL214 sales in 2030E ($1 billion unadjusted). The outlook is supported by…

Guggenheim Maintains Buy Rating for Meta Platforms: Here's What You Need To Know

Guggenheim has decided to maintain its Buy rating of Meta Platforms (NASDAQ:FB) and lower its price target from $275.00 to $250.00. Shares of Meta Platforms are trading down 2.94% over the last 24 hours, at $196.67 per share.

Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2022

What To Know About Guggenheim's Downgrade of Spotify Technology

Guggenheim downgraded its rating of Spotify Technology (NYSE:SPOT) to Neutral with a price target of $95.00, changing its price target from $200.00 to $95.00. Shares of Spotify Technology are trading down 12.12% over the last 24 hours, at $97.03 per share.

inkl

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022

Guggenheim Maintains Buy Rating for Albertsons Companies, Raises Price Target To $37

Guggenheim Maintains Buy Rating for Albertsons Companies, Raises Price Target To $37

Guggenheim has decided to maintain its Buy rating of Albertsons Companies (NYSE:ACI) and raise its price target from $34.00 to $37.00. Shares of Albertsons Companies are trading up 4.41% over the last 24 hours, at $33.38 per share.

Guggenheim Maintains Buy Rating for Rubius Therapeutics, Lowers Price Target To $5

Guggenheim Maintains Buy Rating for Rubius Therapeutics, Lowers Price Target To $5

Guggenheim has decided to maintain its Buy rating of Rubius Therapeutics (NASDAQ:RUBY) and lower its price target from $25.00 to $5.00. Shares of Rubius Therapeutics are trading down 24.14% over the last 24 hours, at $2.42 per share.

Why This Teladoc Health Analyst Expects 25%-30% Revenue Growth

Why This Teladoc Health Analyst Expects 25%-30% Revenue Growth

Teladoc Health Inc (NYSE: TDOC) is a market leader in digital services, and the breadth of its services is unmatched, according to Guggenheim. The Teladoc Health Analyst: Sandy Draper initiated coverage of Teladoc Health with a Buy rating and $96 price target.

Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022

Guggenheim Is Bullish On ESS Tech, Sees Significant Upside

Guggenheim Is Bullish On ESS Tech, Sees Significant Upside

ESS Tech Inc (NYSE:GWH) coverage has been initiated with a Buy rating and a price target of $10 (implying an upside of 82.5%) by Guggenheim analyst Joseph Osha. The analyst cites ESS as one of a large group of companies over the past two decades aiming to make flow batteries work commercially. Osha views ESS…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2022

Analysts Slice Down This Pizza Chain's Price Targets

Analysts lowered their price target on Domino's Pizza Inc (NYSE:DPZ) following the company's Q4 results. Citi analyst Sergio Matsumoto lowered the price target to $480 (18% upside) from $540 and kept a Neutral rating on the shares. The analyst cited forecast decreases and market conditions for the reduced price target. Barclays analyst Jeffrey Bernstein lowered…

45 Stocks Moving In Friday's Mid-Day Session

Gainers KAR Auction Services, Inc. (NYSE: KAR) shares climbed 39.2% to $19.05 after the company agreed to sell its ADESA U.S. physical auction business to Carvana for $2.2 billion. Guggenheim upgraded KAR Auction Services from Sell to Neutral.

Read How Analysts Reacted To IAA's Q4 Results

Truist analyst Stephanie Moore lowered the price target on IAA Inc (NYSE:IAA) to $50 (an upside of 40.5%) from $75 and maintained a Buy rating on the shares. The analyst mentioned the company reported a Q4 EBITDA miss and offered "mixed" FY22 guidance on EBITDA margin, but the subsequent 22% stock price decline is "overdone." Moore…

Get all your
news in one place.

100’s of premium titles.
One news app.

People

Roman Abramovich

Jeffrey Bernstein

Stephanie Moore

Andrew Strelzik

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

344,928 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play